Decelarea fenomenului no-reflow in urma PCI primar la pacientii cu STEMI reprezintă un factor de risc negativ pe termen scurt si lung in ceea ce priveste supravietuirea comparativ cu pacientii care nu asociaza fenomenul. Acest fapt este cu atât mai important in ceea ce priveste mortalitatea pacientilor cu cât s-a dovedit ca exista o corelatie intre fenomenul no-reflow si diabetul zaharat de tip II si obezitate.
Introduction
The no-reflow phenomenon is met by percutaneous coronary intervention in patients who have had a ST segment elevation myocardial infarction, the failure of blood flow to the coronary microcirculation despite the effective disintegration of the artery involved . (1) Diabetes mellitus is a heterogeneous group of disorders with significant lipid and protein- w h e r e s m a l l d i a m e t e r v e s s e l s a n d dismetabolic myocardiopathy . (2) Obesity contributes directly to the alteration of glucose and lipid metabolism, favoring the development of atheromatous plaques, which is mainly explained by the production of negative proinflammatory elements . 
Statistical analysis
The statistical analysis was performed using SPSS 19. We calculated frequency ranges, odds ratio (OR) and 95% confidence interval.
The statistical significance was attributed to p<0.05 value. 
Results

Diabetes
Conclusions
Unlike other studies in the field, it emphasizes the importance of systematically performing basal glycaemia followed by glycosylated hemoglobin, as well as BMI in the risk of detecting the no-reflow phenomenon and mortality compared to patients who do not associate these pathologies .
